Akishima, Japan

Yoshimi Takashima

This inventor holds 3 USPTO granted patents. Top assignees: Showa Denko K.k., Other. Active years: 1981-1985.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshimi Takashima. Retrieved from https://idiyas.com/inventor/yoshimi-takashima

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.6

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 1981-1985

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Yoshimi Takashima

Introduction

Yoshimi Takashima is a notable inventor based in Akishima, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of 3 patents, his work focuses on compounds that have potential therapeutic applications.

Latest Patents

Takashima's latest patents include the development of 2,6,7,8-substituted quinazolines. This compound is produced through a specific process that involves reacting certain chemical formulas with ammonia. The resulting pharmaceutical composition is useful for treating disorders of the circulatory system. Another significant patent involves novel 1-phthalazone derivatives, which also have applications in treating thrombotic diseases.

Career Highlights

Throughout his career, Yoshimi Takashima has worked with various companies, including Showa Denko K.K. His expertise in the pharmaceutical field has led to the development of innovative compounds that address critical health issues.

Collaborations

Takashima has collaborated with notable coworkers such as Masayuki Ishikawa and Hiromichi Tanaka. Their combined efforts have contributed to advancements in pharmaceutical research and development.

Conclusion

Yoshimi Takashima's contributions to the field of pharmaceuticals through his patents highlight his innovative spirit and dedication to improving health outcomes. His work continues to influence the industry and pave the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…